You are here

  • Home
  • Online First
  • Oncological and reproductive outcomes for gonadotropin-releasing hormone agonist combined with aromatase inhibitors or levonorgestrel-releasing intra-uterine system in women with endometrial cancer or atypical endometrial hyperplasia

Article metrics

Article menu

other Versions

Download PDFPDF

Original research
Oncological and reproductive outcomes for gonadotropin-releasing hormone agonist combined with aromatase inhibitors or levonorgestrel-releasing intra-uterine system in women with endometrial cancer or atypical endometrial hyperplasia

 

Online download statistics by month:

Online download statistics by month: November 2022 to April 2024

AbstractFullPdf
Nov 202221221291
Dec 2022575581147
Jan 202395295550
Feb 202324724624
Mar 202311410935
Apr 202313713220
May 2023454317
Jun 2023807730
Jul 2023414021
Aug 2023585714
Sep 2023586215
Oct 2023525112
Nov 2023737225
Dec 2023535330
Jan 20241007633
Feb 2024494214
Mar 2024656052
Apr 2024302812
Total29412896642